Stockreport

OS Therapies Appoints Biotech Industry Luminary Robert "Bob" S. Langer, PhD as Strategic Advisor [Yahoo! Finance]

OS Therapies Incorporated  (OSTX) 
PDF Will assist with listeria oncology pipeline prioritization, combinations with other oncology-focused biotechnologies and tADC candidate selection for further developmen [Read more]